Home NDC 68998-525 Childrens Pain and Fever
Product NDC 68998-525
11-digit product format 689980525
Labeler code 68998
Product ID 68998-525_46533785-5b8c-8897-e063-6394a90a8075
Type HUMAN OTC DRUG
Nonproprietary name ACETAMINOPHEN
Dosage form LIQUID
Route ORAL
Labeler Marc Glassman, Inc.
Application M013
Marketing category OTC MONOGRAPH DRUG
Marketing start 2014-10-10
Substance ACETAMINOPHEN
Active strength 160 mg/5mL
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 68998-525-24 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 68998-525-24 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 68998-525-24 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 68998-525-24 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 68998-525-24 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 68998-525-24 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 68998-525-24 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 68998-525-24 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 68998-525-24 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 68998-525-24 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 68998-525-24 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 68998-525-24 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 68998-525-24 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 68998-525-24 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 68998-525-24 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Childrens Pain and Fever
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACETAMINOPHEN 160 mg/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 362O9ITL9D Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 307668 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68998-525-24 Childrens Pain and Fever 118 mL in 1 BOTTLE LIQUID 118 4
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ACETAMINOPHEN ACTIVE INGREDIENT 362O9ITL9D CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 ACETAMINOPHEN ACTIVE MOIETY 362O9ITL9D CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 ANHYDROUS CITRIC ACID INACTIVE INGREDIENT XF417D3PSL CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 BUTYLPARABEN INACTIVE INGREDIENT 3QPI1U3FV8 CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 CARBOXYMETHYLCELLULOSE SODIUM INACTIVE INGREDIENT K679OBS311 CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 HIGH FRUCTOSE CORN SYRUP INACTIVE INGREDIENT XY6UN3QB6S CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 SORBITOL INACTIVE INGREDIENT 506T60A25R CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 SUCRALOSE INACTIVE INGREDIENT 96K6UQ3ZD4 CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 WATER INACTIVE INGREDIENT 059QF0KO0R CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68998-525 CHILDRENS PAIN AND FEVER (ACETAMINOPHEN) LIQUID [MARC GLASSMAN, INC.] 3 Current NDC, Legacy NDC, 1 package rows 20210101_f708e1ec-cf2a-4e2b-851f-f6b703f359b2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 83 · 1,657 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 68998-525-24 68998052524 118 mL in 1 BOTTLE (68998-525-24) 118 ml 2014-10-10 0000-00-00 No No Current